Scientists create an entirely human model of wound healing by mixing two types of human cells known to be involved with healing – fibroblasts and endothelia cells – into a gel composed of fibrin and collagen. Within three days, blood vessels began to grow in the model, creating vascularized tissue, eliminating the need to torture animals.
A new study is the first to utilize a human cell-based wound closure
model, resulting in novel insights into healing physiology without
inflicting painful wounds on animals.
Researchers at Boston University’s Department of Biomedical Engineering
teamed up with Harvard’s Wyss Institute to create an entirely human model of
wound healing by mixing two types of human cells known to be involved with
healing – fibroblasts and endothelia cells – into a gel composed of fibrin
and collagen. Within three days, blood vessels began to grow in the model,
creating vascularized tissue.
Fibroblasts and endothelia cells
After slicing through this vascularized tissue, the researchers then
spent several days observing how the fabricated wounds healed in real time.
They were able to conclude that, of the two cell types used, fibroblasts are
the key drivers for wound closure.
While animals are typically used to study wound healing and treatments,
scientists admit that there are key differences between the way wounds heal
in animals when compared to humans. For example, in mice and rats, the skin
contracts to close the wound, whereas in humans, granulation tissue forms to
close the wound. Granulation is not needed for wound healing in animals.
Despite these essential differences, thousands of painful and expensive
procedures are carried out to study wounds using animals, typically on mice,
rats, dogs, pigs and sheep.
The National Institute of Arthritis and Musculoskeletal and Skin
Diseases, along with the National Institute of General Medical Sciences are
the main funders of wounding experiments on animals. These experiments
usually involve excising or punching a hole in the skin. In mice this is
sometimes done in the ear. Complications include pain, infection,
malnutrition and death.
The company TRIM-edicine, Inc., in conjunction with Ohio State University,
is using dogs and mice to study their topical treatment for chronic wounds
and has received close to $1 million in NIH funding. Allander
Biotecnologlies, LLC, is using dogs and mice to study the treatment of
excruciating radiation-induced burns, receiving $1.2 million from NIH in
2020 alone.
These outdated and painful animal experiments stand in stark contrast to
the modern, human-relevant, and humane approach developed by the teams at BU
and Harvard. Their wound closure model successfully demonstrates how new
methods in tissue engineering and biomechanical modeling enable scientists
to study the microphysiology of wound healing without harming and killing
animals.
CAARE will continue to push for the replacement of animals by promoting
The
Humane Research and Testing Act, legislation that, if passed will create a
dedicated NIH center for non-animal research to fund and train scientists to
use these new methods.
Return to Alternatives to Animal Testing, Experimentation and Dissection